KennethHyunchungKimMDMHPE
Obstetrics & Gynecology • Dallas, TXGynecologic Oncology
Associate Executive Director and Chief of Medical Practice and Certification Innovation at The American Board of Obstetrics and Gynecology
Dr. Kim is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
2727 Laclede Street
Dallas, TX 75204Phone+1 214-871-1619
Clinical Expertise
- Dermoid cyst, Granulosa cell tumors, Cervical carcinoma, Uterine carcinoma, Ovarian carcinoma, Oncology, Uterine fibroids, Gynecologic oncology, Hereditary breast and ovarian cancer syndrome, Ovarian cancer, Cervical cancer, Wellness, Medical oncology, Instructional Design, Radical abdominal and pelvic cancer surgery, Advanced robotic surgery, Ovarian cancer debulking surgery, Educational theory
Education & Training
University of CincinnatiMHPE, 2016 - 2018
University of Alabama Medical CenterFellowship, Gynecologic Oncology, 2009 - 2012
Ohio State University/Mt Carmel HospitalResidency, Obstetrics and Gynecology, 2005 - 2009
The University of Toledo College of MedicineClass of 2005, MD- Swarthmore CollegeBA, 1997 - 2001
Certifications & Licensure
CA State Medical License 2020 - 2026
AL State Medical License 2009 - 2020
MS State Medical License 2017 - 2020
NC State Medical License 2012 - 2017
OH State Medical License 2005 - 2009- American Board of Obstetrics and Gynecology Obstetrics & Gynecology
- American Board of Obstetrics and Gynecology Gynecologic Oncology
Clinical Trials
- Safety Study of a Genetically Modified Adenovirus in Ovarian Cancer Patients Start of enrollment: 2007 Jun 01
- Safety Study of Farletuzumab, Carboplatin and Pegylated Liposomal Doxorubicin (PLD) to Treat Platinum-sensitive Ovarian Cancer Start of enrollment: 2009 Nov 01
- A Study of an Infectivity Enhanced Suicide Gene Expressing Adenovirus for Ovarian Cancer in Patients With Recurrent Ovarian and Other Selected Gynecologic Cancers Start of enrollment: 2009 Aug 01
- Join now to see all
Publications & Presentations
PubMed
- 23 citationsImpact of an enhanced recovery program for cesarean delivery on postoperative opioid use.S.A. Lester, B. Kim, Michelle D. Tubinis, Charity J. Morgan, Mark F. Powell
International Journal of Obstetric Anesthesia. 2020-01-22 - 30 citationsExtremes in body mass index affect overall survival in women with cervical cancer.Leslie H. Clark, Amanda Jackson, Adrianne E. Soo, D. Orrey, Paola A. Gehrig
Gynecologic Oncology. 2016-06-01 - 62 citationsSimvastatin, an HMG-CoA reductase inhibitor, exhibits anti-metastatic and anti-tumorigenic effects in endometrial cancerMonica N. Schointuch, Timothy P. Gilliam, Jessica E. Stine, Xiaoyun Han, Chunxiao Zhou
Gynecologic Oncology. 2014-08-01
Journal Articles
- Robotics in Gynecologic Oncology: Past, Present, and FutureTaylor KN, Kim KH, Journal of Gynecologic Surgery, 6/28/2023
- The Society of Gynecologic Oncology wellness curriculum pilot: A groundbreaking initiative for fellowship trainingTaylor B Turner, David M Kushner, Abigail Ford Winkel, Gerald McGwin Jr, Stephanie V Blank, Jeffery M Fowler, Kenneth H Kim, Gynecologic Oncology, 1/3/2020
Press Mentions
Quiz Pits Senior Fellows Against Young PhysiciansMay 10th, 2017
Doctors Learn The Nuts And Bolts Of Robotic SurgeryFebruary 23rd, 2022
Training Better Robotic Surgeons in Virtual RealityFebruary 23rd, 2022- Join now to see all
Professional Memberships
- Society of Gynecologic OncologyMember, Board of Directors
- Scientific Program Chair
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
